Reduced Risk of Bleeding With Modern Blood Thinners Aug. 29, 2023 — Modern blood-thinning drugs (known as NOACs) reduce the risk of serious bleeding by up to 45 percent compared to the ...

On Thursday, Bristol Myers Squibb & Co (NYSE:BMY) posted third-quarter revenues of $11.89 billion, beating the consensus of ...

Supplements can be beneficial for filling nutritional gaps, but some can pose health risks, particularly when taken in high ...

Bristol Myers Squibb reported a higher-than-expected third-quarter profit on Thursday, citing strong sales of established ...

A coroner has raised concerns that guidelines around blood thinners do not reflect the most "up to date international ...

Bristol Myers Squibb reported third-quarter earnings and revenue that blew past expectations on strong sales from its blood ...

Also Read: Bristol Myers’ $10B Cancer Drug Opdivo Scores Expanded Use FDA Approval For Lung Cancer In Pre And Post-Surgery Setting Opdivo sales increased 4% to $2.36 billion, and global sales ...

Bristol Myers Squibb posted better-than-expected third-quarter earnings on Thursday citing strong sales of established drugs ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

Blood thinners are essential for many people who undergo procedures to open blocked heart arteries, particularly a treatment known as percutaneous coronary intervention (PCI). During PCI ...